This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Hypera-Takeda deal assigned to CADE Tribunal councilor Azevedo, Tupy-Teksid assigned to Braido

( December 10, 2020, 18:17 GMT | Official Statement) -- MLex Summary: Hypera's planned buyout of certain medicines from Takeda Pharmaceuticals International has been assigned to Brazilian competition authority Tribunal Councilor Paula Farani de Azevedo Silveira, following the Superintendence's opinion that the deal should be approved conditioned on structural remedies. Additionaly, Brazilian metallurgic firm Tupy's planned acquisition of FCA’s metal firm Teksid has been assigned to Councilor Luis Henrique Bertolino Braido, following the Superintendence's recommendation that the deal be blocked.See CADE press release below (in Portuguese)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login